Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - LA JOLLA PHARMACEUTICAL CO | c99163e10vk.htm |
| EX-23.1 - EXHIBIT 23.1 - LA JOLLA PHARMACEUTICAL CO | c99163exv23w1.htm |
| EX-31.1 - EXHIBIT 31.1 - LA JOLLA PHARMACEUTICAL CO | c99163exv31w1.htm |
| EX-21.1 - EXHIBIT 21.1 - LA JOLLA PHARMACEUTICAL CO | c99163exv21w1.htm |
| EX-31.2 - EXHIBIT 31.2 - LA JOLLA PHARMACEUTICAL CO | c99163exv31w2.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Each of the undersigned, in his or her capacity as an officer of La Jolla Pharmaceutical Company
(the “Registrant”), hereby certifies, for purposes of 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| • | the annual report of the Registrant on Form 10-K for the year ended December 31, 2009 (the “Report”), which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| • | the information contained in the Report fairly presents, in all material respects, the financial condition of the Registrant at the end of such year and the results of operations of the Registrant of such year. |
Dated: April 15, 2010
| /s/ Deirdre Y. Gillespie
President, Chief Executive Officer and Assistant Secretary |
||||
| /s/ Gail A. Sloan
Vice President of Finance and Secretary |
Note: A signed original of this written statement required by Section 906 has been provided to La
Jolla Pharmaceutical Company and will be retained by La Jolla Pharmaceutical Company and furnished
to the Securities and Exchange Commission or its staff upon request.